EFFECTIVENESS OF RITUXIMAB TREATMENT IN PATIENTS WITH PRIMARY SJOGREN'S SYNDROME.

被引：0

作者：

Pascual, M. Pavia ^{[1
]}

Rusinovich, O. ^{[1
]}

Rubio, N. de la Torre ^{[1
]}

Palomo, P. Navarro ^{[1
]}

Machattou, M. ^{[1
]}

Godoy, H. ^{[1
]}

Esteban, J. Campos ^{[1
]}

Mateos, C. Barbadillo ^{[1
]}

Sanz, J. ^{[1
]}

Argumanez, C. Merino ^{[1
]}

Espinosa, M. ^{[2
]}

Garcia-Magallon, B. ^{[1
]}

Sanchez, J. L. Andreu ^{[1
]}

Arroyo, A. M. Huerta ^{[3
]}

Castro, M. Fernandez ^{[1
]}

机构：

[1] Puerta Hierro Majadahonda Univ Hosp, Rheumatol, Majadahonda, Spain

[2] Hosp Virgen Rocio, Internal Med, Seville, Spain

[3] Puerta Hierro Majadahonda Univ Hosp, Nephrol, Majadahonda, Spain

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.2044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0430

引用

页码：1343 / 1343

页数：1

共 50 条

[31] Treatment of Primary Sjogren Syndrome With Rituximab A Randomized Trial
Devauchelle-Pensec, Valerie
Mariette, Xavier
Jousse-Joulin, Sandrine
Berthelot, Jean-Marie
Perdriger, Aleth
Puechal, Xavier
Le Guern, Veronique
Sibilia, Jean
Gottenberg, Jacques-Eric
Chiche, Laurent
Hachulla, Eric
Hatron, Pierre Yves
Goeb, Vincent
Hayem, Gilles
Morel, Jacques
Zarnitsky, Charles
Dubost, Jean Jacques
Pers, Jacques Olivier
Nowak, Emmanuel
Saraux, Alain
ANNALS OF INTERNAL MEDICINE, 2014, 160 (04) : 233 - 242
[32] Is rituximab a promising treatment for Sjogren's syndrome?
Devauchelle-Pensec, V.
Pers, J. O.
Youinou, P.
Saraux, A.
REVUE DE MEDECINE INTERNE, 2008, 29 (12): : 967 - 970
[33] Successful treatment of Sjogren's syndrome with rituximab
Touma, Z.
Sayad, J.
Arayssi, T.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (04) : 323 - 325
[34] Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab
Ahmadi-Simab, K
Lamprecht, P
Nölle, B
Ai, M
Gross, WL
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 1087 - 1088
[35] Neurosarcoidosis during the treatment of primary Sjogren's syndrome: is it a paradoxical effect of rituximab?
Cordeiro, R. A.
De Oliveira, J. L.
Ferraciolli, S. F.
Guedes, L. K. N.
Pasoto, S. G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 2464 - 2465
[36] Epratuzumab (anti-CD22) for the treatment of primary \SjoGren's syndrome.
Steinfeld, SD
Pradier, O
Song, I
Burmester, GR
Wegener, WA
Xu, L
Horak, ID
Goldenberg, DM
Tant, L
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S277 - S277
[37] EFFICACY OF RITUXIMAB AND CYCLOPHOSPHAMIDE TREATMENT IN PATIENTS WITH PRIMARY SJOGREN'S SYNDROME AND PAROTID GLAND MALT LYMPHOMA
Torgashina, Anna
Chalcev, Bogdan
Sokol, Evgeniya
Vasiliev, Vladimir
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 786 - 786
[38] Treatment with Abatacept or Rituximab Targets T Follicular Helper Cells in Patients with Primary Sjogren s Syndrome
Verstappen, Gwenny M.
Meiners, Petra M.
Corneth, Odilia B. J.
Hendriks, Rudi W.
Vissink, Arjan
Kroese, Frans G. M.
Bootsma, Hendrika
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[39] Analysis of salivary mucins in primary Sjogren's syndrome.
Goodson, ML
JOURNAL OF DENTAL RESEARCH, 1997, 76 (05) : 1023 - 1023
[40] Spectrum of lymphoproliferative diseases in primary Sjogren's syndrome.
Vasiljev, Vladimir
Probatova, N.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S256 - S257

← 1 2 3 4 5 →